Business
ARIUS to present at Future Leaders in the Biotech Industry conference
ARIUS to present at Future Leaders in the Biotech Industry conference.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\nTORONTO, March 28 /CNW/ - ARIUS Research Inc. (TSX: ARI), a biotechnology\ncompany discovering and developing the next wave of antibody therapeutics,\ntoday announced that David Young, MD, President and Chief Executive Officer,\nhas been invited to speak at the "Future Leaders in the Biotech Industry"\nconference.\n\n\nDr. Young will present on Thursday, March 29th at 3:00pm Eastern Time in\npresentation room 304/305 and will be available following his presentation in\nbreakout room 310. The conference is being held at the Millennium Broadway\nHotel & Conference Center in New York, New York. Dr. Young will provide an\noverview of the company's lead programs in cancer and will update the audience\non milestones leading to first in man studies and business development\nactivities. ARIUS has three lead programs focused on treatments for breast,\nprostate, colon and pancreatic cancers.\n\n\n"Future Leaders in the Biotech Industry" features companies that are best\npositioned to provide market leadership in the biotech industry. The audience\nis comprised of members from the buyside and sellside investment communities.\n\n\nAbout ARIUS\n\n\nARIUS is a biotechnology company discovering and developing the next wave\nof antibody therapeutics. Established in 1999, ARIUS has built a proprietary\ntechnology platform, FunctionFIRST(TM), that rapidly identifies and selects\nantibodies based on their functional ability to affect disease. This antibody\ngeneration engine has enabled ARIUS to assemble a portfolio of more than 400\nantibody candidates. In addition to the antibodies it is developing in-house,\nARIUS has ongoing partnerships with key biotechnology and drug development\ncompanies. ARUIS is listed on the TSX under the symbol "ARI". For further\ninformation, visit www.ariusresearch.com\n\n\nForward-Looking Statements\n\n\nCertain statements in this news release constitute "forward-looking\nstatements" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS...